Back to Search Start Over

P368: A PHASE II STUDY OF INOTUZUMAB OZOGAMICIN FOR THE TREATMENT OF MEASURABLE RESIDUAL DISEASE-POSITIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

Authors :
J. Senapati
H. Kantarjian
N. Short
Y. Alvarado
J. Burger
N. Jain
M. Konopleva
F. Ravandi
C. DiNardo
L. Masarova
K. Sasaki
P. A. Thompson
A. Ferrajoli
J. O. Jacob
E. D. Mayor
A. M. Milton
C. Loiselle
R. S. Garris
E. J. Jabbour
Source :
HemaSphere, Vol 6, Pp 268-269 (2022)
Publication Year :
2022
Publisher :
Wiley, 2022.

Subjects

Subjects :
Diseases of the blood and blood-forming organs
RC633-647.5

Details

Language :
English
ISSN :
25729241 and 00008443
Volume :
6
Database :
Directory of Open Access Journals
Journal :
HemaSphere
Publication Type :
Academic Journal
Accession number :
edsdoj.1d652fe2f53a41f7bcf2220b0309d3e6
Document Type :
article
Full Text :
https://doi.org/10.1097/01.HS9.0000844360.06367.63
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details